Cargando…

Defining distinct features of anti-MOG antibody associated central nervous system demyelination

Extensive research over the last decades basically failed to identify a common cause of noninfectious inflammatory central nervous system (CNS) demyelinating disease. To a great extent, this may reflect that the group of inflammatory CNS demyelinating disorders likely contains multiple pathogenetica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weber, Martin S., Derfuss, Tobias, Metz, Imke, Brück, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881972/ https://www.ncbi.nlm.nih.gov/pubmed/29623106 http://dx.doi.org/10.1177/1756286418762083

Ejemplares similares

MOG antibodies in combined central and peripheral demyelination syndromes
por: Vazquez Do Campo, Rocio, et al.
Publicado: (2018)

Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
por: Spadaro, Melania, et al.
Publicado: (2016)

ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports
por: Körtvélyessy, Peter, et al.
Publicado: (2017)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination
por: Berg, Carsten Tue, et al.
Publicado: (2017)

Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
por: Wendel, Eva Maria, et al.
Publicado: (2022)

Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases
por: Serguera, Che, et al.
Publicado: (2019)

Tumefactive Demyelination—A Rare Presentation of Anti-MOG Syndrome
por: Sivadasan, Sesh, et al.
Publicado: (2022)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)

A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
por: Hochmeister, Sonja, et al.
Publicado: (2020)

Combined Central and Peripheral Demyelination in a Patient of Multifocal Motor Neuropathy and Positive Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibodies
por: Elterefi, Alanood E, et al.
Publicado: (2022)

Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
por: Dale, Russell C., et al.
Publicado: (2014)

Brain histopathological study and prognosis in MOG antibody‐associated demyelinating pseudotumor
por: Shu, Yaqing, et al.
Publicado: (2019)

COVID-19 vaccine associated demyelination & its association with MOG antibody
por: Netravathi, M., et al.
Publicado: (2022)

Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders
por: Rinaldi, Simon, et al.
Publicado: (2020)

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
por: Pröbstel, Anne-Katrin, et al.
Publicado: (2015)

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
por: Ramanathan, Sudarshini, et al.
Publicado: (2018)

Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients
por: Lalive, Patrice H., et al.
Publicado: (2017)

Treatment Approaches for MOG-Ab-Associated Demyelination in Children
por: Hacohen, Yael, et al.
Publicado: (2019)

Epitope specificity of demyelinating MOG-specific autoantibody responses
por: Brehm, U., et al.
Publicado: (1998)

Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis
por: Traub, Jan, et al.
Publicado: (2019)

The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults
por: de Mol, CL, et al.
Publicado: (2019)

Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome
por: Pujari, Shripad S., et al.
Publicado: (2021)

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
por: Schanda, Kathrin, et al.
Publicado: (2021)

Refractory MOG-Associated Demyelinating Disease in a Pediatric Patient
por: Kroenke, Eve, et al.
Publicado: (2022)

Demyelinating Disorders of the Central Nervous System
por: Pirko, Istvan, et al.
Publicado: (2007)

Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients With Central Nervous System Demyelination
por: Ayroza Galvão Ribeiro Gomes, Ana Beatriz, et al.
Publicado: (2023)

Measles–rubella vaccine–associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child
por: Otiv, Madhumati, et al.
Publicado: (2022)

Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies
por: Wegener-Panzer, Andreas, et al.
Publicado: (2020)

Antibody signatures in patients with histopathologically defined multiple sclerosis patterns
por: Stork, Lidia, et al.
Publicado: (2020)

Inflammatory demyelinating diseases of the central nervous system
por: Höftberger, Romana, et al.
Publicado: (2018)

Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases
por: Jiao, Li, et al.
Publicado: (2022)

Identification of circulating MOG-specific B cells in patients with MOG antibodies
por: Winklmeier, Stephan, et al.
Publicado: (2019)

Vitamin D Supplementation in Central Nervous System Demyelinating Disease—Enough Is Enough
por: Häusler, Darius, et al.
Publicado: (2019)

Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination
por: Pechlivanidou, Maria, et al.
Publicado: (2023)

MOG antibody-associated diseases
por: Reindl, Markus, et al.
Publicado: (2015)

B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination
por: Kothur, Kavitha, et al.
Publicado: (2016)

Antibody cross-reactivity between casein and myelin-associated glycoprotein results in central nervous system demyelination
por: Chunder, Rittika, et al.
Publicado: (2022)

Central nervous system inflammatory demyelinating disorders of childhood
por: Kamate, Mahesh, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fqq424nebds4mm85eoh8jh482c